Endurant Capital Management LP - MOLECULAR TEMPLATES INC ownership

Quarter-by-quarter ownership
Endurant Capital Management LP ownership history of MOLECULAR TEMPLATES INC
ValueSharesWeighting
Q1 2022$1,084,000
+3.0%
314,238
+17.1%
0.29%
+12.6%
Q4 2021$1,052,000
-74.4%
268,375
-56.3%
0.25%
-72.9%
Q3 2021$4,117,000
-29.6%
613,630
-18.0%
0.94%
-41.7%
Q2 2021$5,849,000
-34.7%
748,013
+5.4%
1.61%
-31.1%
Q1 2021$8,952,000
+39.9%
709,360
+4.1%
2.33%
+1.2%
Q4 2020$6,397,000
+38.6%
681,243
+61.1%
2.31%
+69.0%
Q3 2020$4,617,000
+45.7%
422,787
+84.0%
1.36%
+684.5%
Q2 2020$3,169,000229,8170.17%
Other shareholders
MOLECULAR TEMPLATES INC shareholders Q3 2023
NameSharesValueWeighting ↓
CAXTON CORP 2,137,991$8,381,0006.85%
ACUTA CAPITAL PARTNERS, LLC 322,500$1,264,0000.53%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,021,317$4,004,0000.46%
BVF INC/IL 3,129,599$12,268,0000.44%
Bellevue Group AG 10,878,003$42,642,0000.44%
FRAZIER MANAGEMENT LLC 1,374,047$5,386,0000.42%
Endurant Capital Management LP 268,375$1,052,0000.25%
Abingworth LLP 200,000$780,0000.19%
Parkman Healthcare Partners LLC 147,728$579,0000.13%
GSA CAPITAL PARTNERS LLP 145,329$570,0000.07%
View complete list of MOLECULAR TEMPLATES INC shareholders